Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

International Biobanking for Lung Cancer and COPD as the Future Resource for Clinical Protein Research

In English

Författare

Summary, in English

Characterized tissue with pathological grading and blood samples as well as other biofluids forms the basis for all biobanks as a resource in modern life science. Biobanks are accessed to measure biological components that can be used to monitor the status of health and disease in individual samples and population groups. The biomarker diagnostics area, predicting drug efficacy, stratification of patient groups, can benefit from the continuous qualitative developments, where Proteomics can make a difference in lung cancer and COPD. This in turn can provide key treasures to novel drugs for personalized medicine in the future.

Publiceringsår

2013

Språk

Engelska

Sidor

3-7

Publikation/Tidskrift/Serie

EuPA Open Proteomics

Volym

1

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Medical Engineering

Nyckelord

  • Lung Cancer
  • COPD
  • Biobank
  • Pathology

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 2212-9685